title: Strategic selective treatment in highly pre-treated HIV patients harbouring multiply resistant viruses.
authors.forename: Franco
authors.initials: F
authors.lastname: Maggiolo
authors.forename: Annapaola
authors.initials: A
authors.lastname: Callegaro
authors.forename: Giampietro
authors.initials: G
authors.lastname: Gregis
authors.forename: Giampaolo
authors.initials: G
authors.lastname: Quinzan
authors.forename: Diego
authors.initials: D
authors.lastname: Ripamonti
authors.forename: Claudio
authors.initials: C
authors.lastname: Arici
authors.forename: Antonio
authors.initials: A
authors.lastname: Goglio
authors.forename: Fredy
authors.initials: F
authors.lastname: Suter
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D024921:Drug Resistance, Multiple, Viral; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects* / Q000276:immunology / Q000502:physiology; D006801:Humans; D008297:Male; D011446:Prospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D014779:Virus Replication / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors